Colorectal cancer 1

Common Name(s)

Colorectal cancer 1

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Colorectal cancer 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Colorectal cancer 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Colorectal cancer 1" returned 445 free, full-text research articles on human participants. First 3 results:

Correlations of ICAM-1 gene polymorphisms with susceptibility and multidrug resistance in colorectal cancer in a Chinese population.
 

Author(s): Lu-Bing Liu, Tong Liu, Fu-Ze Xin

Journal: Medicine (Baltimore). 2017 Aug;96(33):e7481.

 

Colorectal cancer (CRC) is a malignant gastrointestinal tumor with a high mortality rate, including both colon and rectal cancer. In order to provide clinical guidance for the treatment of CRC, this study is conducted to investigate the correlations of intercellular adhesion molecule ...

Last Updated: 17 Aug 2017

Go To URL
microRNA-219-5p inhibits epithelial-mesenchymal transition and metastasis of colorectal cancer by targeting lymphoid enhancer-binding factor 1.
 

Author(s): Lan-Xuan Huang, Chun-Yan Hu, Li Jing, Min-Cong Wang, Meng Xu, Jing Wang, Yu Wang, Ke-Jun Nan, Shu-Hong Wang

Journal: Cancer Sci.. 2017 Oct;108(10):1985-1995.

 

Aberrant expression of microRNAs (miRs) has been shown to play a critical role in the pathogenesis and progression of tumors. microRNA-219-5p (miR-219-5p) has been reported to be abnormally expressed in some types of human tumors. However, the mechanism between miR-219-5p and colorectal ...

Last Updated: 3 Aug 2017

Go To URL
Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer: Regimen of 1 week on, 1 week off.
 

Author(s): Jin Li, Ruihua Xu, Jianming Xu, Tadamichi Denda, Koji Ikejiri, Lin Shen, Yasushi Toh, Ken Shimada, Takeshi Kato, Kenji Sakai, Manabu Yamamoto, Hideyuki Mishima, Jinwan Wang, Hideo Baba

Journal: Cancer Sci.. 2017 Oct;108(10):2045-2051.

 

A phase II study of S-1 plus leucovorin (LV) given in a 4-week schedule (2 weeks' administration followed by 2 weeks' rest) for patients with untreated metastatic colorectal cancer (mCRC) showed that the combination was effective, but grade 3 toxicities (diarrhea, stomatitis and anorexia) ...

Last Updated: 1 Aug 2017

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Colorectal cancer 1" returned 4 free, full-text review articles on human participants. First 3 results:

Prognostic and clinical significance of syndecan-1 in colorectal cancer: a meta-analysis.
 

Author(s): Hao-Tang Wei, Er-Na Guo, Bao-Guo Dong, Li-Sheng Chen

Journal:

 

Syndecan-1 plays a vital role in the suppression, transformation, and migration of several cancer types, including colorectal cancer (CRC). However, the prognostic and clinical significance of syndecan-1 in CRC remains conflicting. Therefore, we performed a meta-analysis to clarify ...

Last Updated: 31 Oct 2015

Go To URL
STAT3 and sphingosine-1-phosphate in inflammation-associated colorectal cancer.
 

Author(s): Andrew V Nguyen, Yuan-Yuan Wu, Elaine Y Lin

Journal: World J. Gastroenterol.. 2014 Aug;20(30):10279-87.

 

Accumulated evidences have demonstrated that signal transducer and activator of transcription 3 (STAT3) is a critical link between inflammation and cancer. Multiple studies have indicated that persistent activation of STAT3 in epithelial/tumor cells in inflammation-associated colorectal ...

Last Updated: 18 Aug 2014

Go To URL
Antineoplastic effects of 1,25(OH)2D3 and its analogs in breast, prostate and colorectal cancer.
 

Author(s): Carlien Leyssens, Lieve Verlinden, Annemieke Verstuyf

Journal:

 

The active form of vitamin D3, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), is mostly known for its importance in the maintenance of calcium and phosphate homeostasis. However, next to its classical effects on bone, kidney and intestine, 1,25(OH)2D3 also exerts antineoplastic effects on ...

Last Updated: 25 Mar 2013

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

High-dose FOLFIRI in Advanced Colorectal Cancer Patients With Wild-type UGT1A1*6 and *28
 

Status: Recruiting

Condition Summary: Colorectal Cancer

 

Last Updated: 31 Oct 2017

Go to URL
To Determine the MTD and to Evaluate the Safety, Efficacy and PK Profiles of TSB-9-W1 in Pre-treated Patients With mCRC.
 

Status: Not yet recruiting

Condition Summary: Metastatic Colorectal Cancer

 

Last Updated: 22 Apr 2016

Go to URL

Last Updated: 7 Dec 2016

Go to URL